107 related articles for article (PubMed ID: 15077184)
1. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.
Liu H; Chen B; Xiong H; Huang QH; Zhang QH; Wang ZG; Li BL; Chen Z; Chen SJ
Oncogene; 2004 Apr; 23(19):3385-94. PubMed ID: 15077184
[TBL] [Abstract][Full Text] [Related]
2. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
[TBL] [Abstract][Full Text] [Related]
4. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation.
Sun Q; Kong CT; Huang FP; Chan LC
J Leukoc Biol; 2008 Jan; 83(1):173-80. PubMed ID: 17895399
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein.
Yam JW; Jin DY; So CW; Chan LC
Blood; 2004 Feb; 103(4):1445-53. PubMed ID: 14551139
[TBL] [Abstract][Full Text] [Related]
6. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
[TBL] [Abstract][Full Text] [Related]
7. Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis.
Ma LH; Liu H; Xiong H; Chen B; Zhang XW; Wang YY; Le HY; Huang QH; Zhang QH; Li BL; Chen Z; Chen SJ
Blood; 2007 Jan; 109(2):769-77. PubMed ID: 16990610
[TBL] [Abstract][Full Text] [Related]
8. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
[TBL] [Abstract][Full Text] [Related]
9. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
10. A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.
Chinwalla V; Chien A; Odero M; Neilly MB; Zeleznik-Le NJ; Rowley JD
Oncogene; 2003 Mar; 22(9):1400-10. PubMed ID: 12618766
[TBL] [Abstract][Full Text] [Related]
11. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
[TBL] [Abstract][Full Text] [Related]
12. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
[TBL] [Abstract][Full Text] [Related]
13. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T
Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
[TBL] [Abstract][Full Text] [Related]
16. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
17. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model.
Ng RK; Kong CT; So CC; Lui WC; Chan YF; Leung KC; So KC; Tsang HM; Chan LC; Sham MH
J Pathol; 2014 Jan; 232(1):65-74. PubMed ID: 24122813
[TBL] [Abstract][Full Text] [Related]
19. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis.
So CW; So CK; Cheung N; Chew SL; Sham MH; Chan LC
Leukemia; 2000 Apr; 14(4):594-601. PubMed ID: 10764144
[TBL] [Abstract][Full Text] [Related]
20. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
